WHO ICTRP trial
Clinical trial of human (allogeneic) induced pluripotent stem cell-derived…
JPRN-UMIN000032989 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000032989 |
|---|---|
| Public title | Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathy |
| Scientific title | Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathy - Clinical trial of human (allogeneic) iPS cell-derived cardiomyocyte sheet for severe cardiomyopathy |
| Primary sponsor | Osaka University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I,II |
| Countries | Japan |
| Conditions | Ischemic cardiomyopathy |
| Interventions | Human (allogeneic) iPS cell derived-cardiomyocyte sheet transplantation |
| Registration date | Jun 15, 2018 |
| Target size | 3 |
| Secondary IDs | PA8170002 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: